[논문]Malononitrilamides 715 and 279 prevent accelerated cardiac allograft rejection synergistically with cyclosporin A in presensitized rats

doi:10.1016/S0966-3274(98)80023-3

[해외논문] Malononitrilamides 715 and 279 prevent accelerated cardiac allograft rejection synergistically with cyclosporin A in presensitized rats

Transplant immunology, v.6 no.2, 1998년, pp.94 - 100

Qi, Zhongquan (Department of Experimental Research, Lund University, University Hospital, Malmo, Sweden) , Simanaitis, Mecislovas (Department of Pathology, Lund University, University Hospital, Malmo, Sweden) , Ekberg, Henrik (Address for correspondence: H Ekberg, Department of Vascular and Renal Diseases, Lund University, University Hospital, S-205 02 Malmo, Sweden)

Abstract ▼ AI-Helper

AbstractA77 1726 is a malononitrilarnide (MNA) and the active metabolite of leflunomide. Leflunomide has been extensively investigated and shown to be a potent immunosuppressive drug. However, the half-life of A77 1726 is about 15–18 days in humans and the leflunomide is, therefore, currently being evaluated for the treatment of autoimmune disease and not for transplantation. The search for analogues has led to the development of MNA 715 and 279, derivatives of A77 1726. Previous limited experimental experience has shown these MNAs to prevent skin allograft and xenograft rejection and graft-versus-host disease in rodents, and to reverse ongoing allograft rejection. The aim of the present study was to verify the efficacy of these MNAs in a cardiac retransplant model of sensitized rats, concerning prevention of accelerated rejection, inhibition of antibody production and interaction with cyclosporin A (CsA).Heterotopic cardiac transplantation and retransplantation in Dark Agouti (DA) to Peibald Virol Glaxo (PVG) rats was used. Subgroups of rats were given either CsA, MNA 715, MNA 279 or combined CsA/MNA for 10 days starting either day 0 or day −1, as of regrafting or no treatment. Titres of allospecific IgM and IgG were quantitated by flow cytometry.Ten days of MNA 715 or 279 from day −1 prevented accelerated rejection of the retransplant, as did CsA. Neither treatment given from day 0 prevented rejection within 24 h. However, a combination of MNA 715 or 279 and CsA from day 0 effectively prevented accelerated regraft rejection. Production of specific alloantibodies was reduced in all immunosuppressed subgroups, IgG titres at day 7 in MNA-treated subgroups being significantly lower compared with those in the CsA-treated subgroup.In conclusion, MNA 715 and 279 were shown to be potent immunosuppressants with the capacity to prevent accelerated regraft rejection in rat cardiac transplants, most efficiently in combination with CsA, and to suppress specific alloantibody production.

참고문헌 (35)

Acta Chir Scand Xu 52 527 1996 Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation
J Heart Lung Transplant Cao 14 1016 1995 Mechanism of the antiproliferative action of leflunomide, A77 1726, the active metabolite of leflunomide, does not block T-cell receptor-mediated signal transduction but its antiproliferative effects are antagonized by pyrimidine nucleosides
Biochemistry Davies 35 1270 1996 10.1021/bi952168g The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase

상세보기
J Biol Chem Williamson 270 22467 1995 10.1074/jbc.270.38.22467 Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound

상세보기
Int J Immunopharmacol Bartlett 8 199 1986 10.1016/0192-0561(86)90059-7 Immunopharmacological profile of HWA 486, a novel isoxazol derivative - II. In vivo immunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A

상세보기
Transplant Proc Dimitrijevic 28 3086 1996 Leflunomide, a novel immunomodulating drug, inhibits homotypic adhesion of mononuclear cells in rheumatoid arthritis

상세보기
Transplantation Chong 61 140 1996 10.1097/00007890-199601150-00026 Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro

상세보기
Transplantation Siemasko 61 635 1996 10.1097/00007890-199602270-00020 Regulation of B cell function by the immunosuppressive agent leflunomide

상세보기
Transplant Proc Kurrie 29 1302 1997 10.1016/S0041-1345(96)00528-3 Malononitrilamides inhibit T- and B-cell responsiveness in different species

상세보기
Transplant Proc Kurrle 28 3053 1996 Malononitrilamides inhibit T- and B-cell responsiveness

상세보기
Transplant Proc Czech 28 3051 1996 Effect of malononitrilamides on human bone marrow

상세보기
Transplant Proc Schorlemmer 28 3048 1996 Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides

상세보기
Transplant Proc Lin 28 3036 1996 Efficacy of the malononitrilamide X 920715 as compared with leflunomide in cardiac allo- and xeno-transplantation in rats

상세보기
Scand J Immunol Qi 1998 10.1046/j.1365-3083.1998.00409.x Malononitrilamides (MNAs) prolong rat cardiac allograft survival, reverse ongoing acute rejection, inhibit allospecific antibody synthesis and interact positively with cyclosporin

상세보기
Transplant Proc Schorlemmer 28 3037 1996 Control of mouse-to-rat skin xeno graft rejection by malononitrilarnides
Transplant Proc Sehorlemmer 29 1298 1997 10.1016/S0041-1345(96)00526-X Analogues of leflunomide's primary metabolite, the malononitrilamides, prevent the development of graft-versus-host disease

상세보기
Transplant Proc Schorlemmer 28 3043 1996 Malononitrilamides inhibit the development of various murine graft-vs-host diseases

상세보기
Acta Chir Scand Olausson 150 463 1984 Non-suture organ grafting to the neck vessels in rats

상세보기
Transplantation Wasowska 53 175 1992 10.1097/00007890-199201000-00035 IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival

상세보기
Am J Med Sci Silva Junior 313 289 1997 10.1097/00000441-199705000-00008 Leflunomide and malononitrilamides

상세보기
Agents Actions Bartlett 32 10 1991 10.1007/BF01983301 Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection

상세보기
Transplantation Hancock 64 696 1997 10.1097/00007890-199709150-00006 Effects of leflunomide and deoxyspergualin in the guinea pig to rat cardiac model of delayed xenograft rejection

상세보기
Transplantation D'Silva 60 430 1995 10.1097/00007890-199509000-00005 The immunomodulatory effect of leflunomide in rat cardiac allotransplantation

상세보기
Transplantation Williams 57 1223 1994 10.1097/00007890-199404270-00015 Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine

상세보기
Kidney Int Suppl Lin 52 S23 1995 Effect of Leflunomide arid cyclosporine on the occurrence of chronic xenograft lesions
Transplantation Yehb 62 861 1996 10.1097/00007890-199609270-00027 Effects of leflunomide and cyclosporine on myocutaneous allograft survival in the rat

상세보기
Transplantation McChesney 57 1717 1994 10.1097/00007890-199457120-00005 An evaluation of leflunomide in the canine renal transplantation model

상세보기
Arthritis Rheum Miadenovic 38 1595 1995 10.1002/art.1780381111 Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controllied, phase II study

상세보기
Transplant Proc Cheung 29 1294 1997 10.1016/S0041-1345(96)00524-6 Leflunomide abrogates accelerated heart allograft rejection in presensitized rats

상세보기
Transplantation Chong 55 1361 1993 10.1097/00007890-199306000-00028 Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation

상세보기
Transplantation Xiao 58 828 1994 10.1097/00007890-199410150-00014 Leflunomide controls rejection in hamster to rat cardiac xenografts

상세보기
Scand J Immunol Berger 17 241 1983 10.1111/j.1365-3083.1983.tb00787.x In vitro effects of cyclosporin A on human B-cell responses

상세보기
Drugs Exp Clin Res Lun 17 493 1991 Effect of cyclosporin A on B cell maturation and differentiation

상세보기
J Pharmacol Exp Ther Cherwinski 272 460 1995 The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism

상세보기
Transplantation Lang 59 382 1995 10.1097/00007890-199502150-00013 Differential effects of the immunosuppressive agents cyclosporine and leflunornide in vivo. Leflunomide blocks clonal T cell expansion yet allows production of lymphokines and manifestation of T cell-mediated shock

상세보기

원문 URL 링크

DOI : 10.1016/S0966-3274(98)80023-3
OCLC ECO : 저널
Elsevier : 저널 > 논문

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

저작권 관리 안내

내보내기 메뉴

내보내기 구분

파일저장
인쇄
메일전송

구성항목

기본정보
상세정보

관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관

저장형식

Text(ASCII format)
Excel format
RefWorks Direct Export
RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley

메일정보

받는사람 (필수): @
보내는사람 (선택): @
제목
내용: KISTI 검색결과 이메일 서비스

안내

총 건의 자료가 검색되었습니다.

다운받으실 자료의 인덱스를 입력하세요. (1-10,000)

검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다.

데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요)

다운로드 파일은 UTF-8 형태로 저장됩니다.
파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오.

Text(ASCII format)
Excel format

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

AI-Helper ※ AI-Helper는 을 사용합니다.

AI-Helper

안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

연합인증

[해외논문] Malononitrilamides 715 and 279 prevent accelerated cardiac allograft rejection synergistically with cyclosporin A in presensitized rats

Abstract ▼ AI-Helper

참고문헌 (35)

이 논문을 인용한 문헌

관련 콘텐츠

원문 URL 링크

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format